Anekwe Onwuanyi to Stroke Volume
This is a "connection" page, showing publications Anekwe Onwuanyi has written about Stroke Volume.
Connection Strength
1.511
-
Egbuche O, Hanna B, Onuorah I, Uko E, Taha Y, Ghali JK, Onwuanyi A. Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review. Curr Cardiol Rev. 2020; 16(1):55-64.
Score: 0.598
-
Egbuche O, Ekechukwu I, Effoe V, Maduabum N, Millard HR, Maihemuti A, Cross JA, Adedinsewo D, Onwuanyi AE. Effect of ?-blocker Therapy on Hospital Readmission and Mortality in Heart Failure Patients With Concurrent Cocaine Use. J Cardiovasc Pharmacol Ther. 2018 11; 23(6):518-523.
Score: 0.535
-
Rosano GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, Chioncel O, Fang J, Greenberg B, Ibrahim NE, Imamura T, Inomata T, Kuwahara K, Moura B, Onwuanyi A, Sato N, Savarese G, Sakata Y, Sweitzer N, Wilcox J, Yamamoto K, Metra M, Coats AJS. The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS). Eur J Heart Fail. 2025 Jul; 27(7):1174-1187.
Score: 0.216
-
Goldenberg I, Zareba W, Ezekowitz JA, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Harrington JM, Hsich E, Huang DT, Januzzi JL, Jawaid A, Kutyifa V, Lala-Trindade A, Nakonechnyi A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Baykaner T, Strawderman R, Beck C, Butler J. Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial. Am Heart J. 2026 Jan; 291:162-174.
Score: 0.055
-
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. J Card Fail. 2025 Aug; 31(8):1326-1338.
Score: 0.053
-
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J. Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure. Heart Rhythm. 2025 Apr; 22(4):1040-1051.
Score: 0.053